Piramal Pharma Limited Announces Results for Q3 and 9M FY26
4 February 2026
No Comments
Mumbai, India | January 28, 2026: Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635),
Tag: Piramal Pharma Solutions
Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities
4 February 2026
No Comments
Piramal Pharma Solutions continues to lead its advanced dosage form expertise by successfully developing
PIRAMAL PHARMA SOLUTIONS ANNOUNCES PRODUCTION OF FIRST BATCHES AT NEW API FACILITY IN RIVERVIEW, MICHIGAN
21 February 2023
No Comments
New manufacturing facility dedicated to the production of active pharmaceutical ingredients (APIs) and high
